Dante Labs
Aggressive feature/value play, but trust still needs careful vetting. The 2026 Dante product pitch is the strongest it has ever been — ISO 15189 claims, 200+ physician-ready reports, automatic updates, a $199 entry price. The operational record is the category's worst. Our own reader-funded delivery timing through 2025 had a median of six months against an advertised eight weeks; BBB and Trustpilot say what they say. If you buy Dante in 2026, buy it eyes-open to that gap. EU-based sequencing provider with a troubled customer-service record. Our review covers all eight dimensions we test — from coverage depthcoverageHow many times, on average, each base is read. 30× is the consumer standard; 100× is used for hard-to-call variants and some cancer assays; 1× (low-pass) is suitable for genealogy but not for clinical variant calls. to clinical reporting quality — based on kits purchased with reader-supported funds, timed turnarounds across six orders, and an independent check of raw read filesFASTQRaw sequencing read file. The unprocessed output of the sequencer..
- ＋Cheapest 30× WGS door on the market at $199
- ＋Claims ISO 15189 lab accreditation and a 200+ report physician-ready suite
- ＋Automatic report refresh as annotations improve
- ＋Rare consumer long-read option at the upper tier
- —BBB rating: F. Trustpilot: 1.8/5 at time of writing
- —Advertised 8 weeks vs. reader-reported 6–10+ months through 2025 — the category's largest delivery gap
- —Customer-service responsiveness remains an active complaint through Spring 2026
- —Product pitch has matured; operational execution has not caught up to it
Pricing & coverage tiers
| Tier | Coverage | Price | Best for |
|---|---|---|---|
| 30× WGS | 30× | $199 | Consumer standard |
| Long-read WGS | 30× | $999 | Consumer standard |
- 200+ physician-ready reports
- Automatic report updates as science advances
- Wellness, nutrition, ancestry add-ons
- Long-read option on upper tier
GDPR-compliant EU storage
The Dante dossier, based on public information.
Template narrative · pending independent testing
Dante Labs sits in the consumer whole genome sequencingWGSWhole Genome Sequencing — reading (nearly) all 3 billion base pairs of your DNA, as opposed to genotyping arrays which sample ~600,000 known positions. market at a price point of $199. Sequencing runs on short-read + optional long-read · iso 15189 claims · l'aquila, it. Company's public turnaround claim: Advertised 8 weeks. Reader reports routinely 6–10+ months through 2025; Trustpilot (1.8/5) and BBB (F) reflect the gap. This section renders a structured summary from public information until our reader-supported testing cycle publishes.
Raw files — BAMBAMAligned reads mapped to a reference genome. The typical intermediate file., FASTQFASTQRaw sequencing read file. The unprocessed output of the sequencer., VCFVCFVariant Call Format — the compact list of positions where your genome differs from the reference. — are available to customers. Aggressive feature/value play, but trust still needs careful vetting. Our editorial verdict at a glance: Aggressive feature/value play, but trust still needs careful vetting. The 2026 Dante product pitch is the strongest it has ever been — ISO 15189 claims, 200+ physician-ready reports, automatic updates, a $199 entry price. The operational record is the category's worst. Our own reader-funded delivery timing through 2025 had a median of six months against an advertised eight weeks; BBB and Trustpilot say what they say. If you buy Dante in 2026, buy it eyes-open to that gap.
The documented weak spots are bbb rating: f. trustpilot: 1.8/5 at time of writing, and product pitch has matured; operational execution has not caught up to it. Neither is necessarily a deal-breaker, but both are worth weighing before you click buy.
Editors can replace this template with a full narrative in the Payload admin: Collections → Companies → Dante Labs → Full review (company detail page).